| Digital Human-Based Brief Interventions for Harmful Alcohol Use: The PAHOLA Project (NCT05906979) | Centre for Addiction and Mental Health | 2022-05-01 |
| The Man Van Project (NCT06357416) | Royal Marsden NHS Foundation Trust | 2022-04-13 |
| Naltrexone in AUD Reward Drinkers (NCT05028062) | University of Pennsylvania | 2022-03-07 |
| Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder (NCT05093296) | Central Institute of Mental Health, Mannheim | 2021-12-02 |
| Amplification of Positivity for Alcohol Use Disorder Co-Occurring With Anxiety or Depression (NCT04934553) | Charles Taylor | 2021-05-20 |
| Pilot Study to Evaluate "Intégrer et Accompagner Les Consommations d'Alcool!" (IACA!)'s Impact and Transferability (NCT04927455) | University Hospital, Bordeaux | 2021-04-16 |
| Effectiveness of High-frequency rTMS in Reducing Alcohol Consumption in Non-abstinent Patients With an Alcohol Use Disorder (NCT04773691) | Centre Hospitalier Universitaire Dijon | 2021-03-01 |
| PTSD, AUD, and Interpersonal Conflict: Within-person Associations (NCT04552782) | University of South Dakota | 2020-12-04 |
| Alcohol and Women : Screening in General (NCT04647565) | University Hospital, Montpellier | 2020-12-01 |
| Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer (NCT05992272) | Charite University, Berlin, Germany | 2020-11-24 |
| Investigation of the Efficacy of Acamprosate and Calcium in Comparison to Placebo as Validation of a Behavioural Test for Alcohol Dependence (NCT03634917) | Technische Universität Dresden | 2020-08-05 |
| Neuroimmune Dysfunction in Alcohol Use Disorder (NCT04210713) | University of Maryland, Baltimore | 2020-02-03 |
| Evaluation of Physical Activity of Patients Admitted to Addiction Service (NCT04953403) | University Hospital, Montpellier | 2020-01-01 |
| Impact of Integrating an Addiction Team on Post Liver Transplantation Survival for Alcohol-related Liver Disease and Its Complications. (NCT04964687) | University Hospital, Montpellier | 2019-10-01 |
| Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder (NCT03969251) | Nassima Ait-Daoud Tiouririne | 2019-07-11 |
| Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence (NCT02120365) | Virginia Commonwealth University | 2019-06-01 |
| Vortioxetine for Treatment of Depressive Mood and Alcohol Use (NCT04498897) | Hanyang University Seoul Hospital | 2019-01-25 |
| Impact of Marketing of Alcohol Products on Young People (NCT03818750) | Rennes University Hospital | 2018-06-13 |
| Behavioral Alcohol Responses (BAR) Study (NCT03467191) | Carnegie Mellon University | 2018-02-13 |
| A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study) (NCT03060772) | Emory University | 2018-01-03 |
| Understanding Alcohol Reward in Social Context (NCT03449095) | University of Illinois at Urbana-Champaign | 2017-11-04 |
| Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study (NCT03339024) | Norwegian University of Science and Technology | 2017-11-01 |
| Ketogenic Diet (KD) in Alcoholism (NCT03255031) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2017-10-24 |
| Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder Via Microbiota Investigations: A Pilot Study (NCT03152760) | National Institute on Drug Abuse (NIDA) | 2017-08-28 |
| Recognition and Early Intervention for Alcohol and Substance Abuse in Adolescence in Adolescent (NCT06262958) | Kuopio University Hospital | 2017-08-07 |
| Dietary Fiber Intake in Alcohol-dependent Patients (NCT03803709) | Université Catholique de Louvain | 2017-07-04 |
| Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder (NCT03120468) | Nassima Ait-Daoud Tiouririne | 2017-05-01 |
| Testing Doxazosin to Treat Stress Mechanisms in Alcoholism (NCT02989493) | University of Wisconsin, Madison | 2017-04-12 |
| Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality (NCT02668250) | Centre Hospitalier Universitaire de Saint Etienne | 2017-02-03 |
| Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home (NCT02885311) | Northwell Health | 2017-01-01 |
| Mindfulness-Based Intervention and Transcranial Direct Current Brain Stimulation to Reduce Heavy Drinking (NCT02861807) | University of New Mexico | 2016-11-22 |
| Computerized Alcohol Misuse Intervention System for Health Care (NCT02368899) | Research Circle Associates, LLC | 2016-11-01 |
| Aripiprazole for Bipolar Disorder and Alcohol Use Disorder (NCT02918370) | University of Texas Southwestern Medical Center | 2016-11-01 |
| Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment (NCT02966340) | University of Wisconsin, Madison | 2016-11-01 |
| Oxytocin and Alcohol Withdrawal and Dependence (NCT02903251) | Norwegian University of Science and Technology | 2016-10-01 |
| Individualized Assessment and Treatment for Alcoholism II (NCT03233802) | UConn Health | 2016-08-01 |
| Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU (NCT02723383) | Nantes University Hospital | 2016-06-27 |
| A Novel Compound for Alcoholism Treatment: A Translational Strategy - Part II (NCT02707055) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2016-06-15 |
| Alcohol Addiction: A Systems-oriented Approach (NCT02910193) | Charite University, Berlin, Germany | 2016-05-17 |
| Trial of a Multi-pronged Intervention to Address Prevention of Violence in Zambia (NCT02790827) | Johns Hopkins Bloomberg School of Public Health | 2016-05-01 |
| HIV & Drug Abuse Prevention for South African Men (NCT02358226) | University of California, Los Angeles | 2016-05-01 |
| Oxytocin in Alcohol Use Disorder (NCT02711189) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2016-03-08 |
| Treatment Engagement With Technology-assisted Treatment (NCT02674477) | Johns Hopkins University | 2016-02-29 |
| Validation of a Test System for Development of Medications for Alcoholism (NCT02652585) | Technische Universität Dresden | 2016-02-01 |
| The Effects of Oxytocin on Startle Hyperreactivity in Patients With AUD and PTSD (NCT02469259) | University of California, San Francisco | 2016-02-01 |
| New Therapeutic Strategies for Inhibitory Control in Alcoholism (NCT03058276) | Hospital Universitario 12 de Octubre | 2016-01-01 |
| New Therapeutic Strategies for the Treatment of Alcohol Use Disorders (NCT03028662) | Gabriel Rubio Valladolid, MD | 2016-01-01 |
| Suicidal Behavior in Patients Diagnosed With Bipolar Disorder (NCT02604277) | Emory University | 2016-01-01 |
| Usability Study for SOBERLINK System (NCT02650180) | Soberlink Healthcare LLC | 2015-12-01 |
| Prevention of Fetal Alcohol Spectrum Disorder (FASD) by the Use of Technology (NCT02759874) | Institute of Health Economics, Canada | 2015-11-01 |
| Evaluating Interventions for Alcohol Use Disorder (NCT02409888) | Rutgers, The State University of New Jersey | 2015-11-01 |
| Clinical Study of TripleA for Treatment of Alcohol Addiction in Outpatient Care (NCT03195894) | Kontigo Care AB | 2015-10-01 |
| Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services (NCT02233738) | VA Office of Research and Development | 2015-09-30 |
| Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults (NCT00890149) | University of Maryland, Baltimore | 2015-09-01 |
| Gut Hormones in Obesity, Nicotine and Alcohol Dependence (NCT02690987) | Imperial College London | 2015-08-01 |
| Supportive Text Messages to Reduce Mood Symptoms and Problem Drinking- Randomised Controlled Pilot Trials (NCT02327858) | University of Alberta | 2015-07-01 |
| Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity (NCT02372318) | Central Institute of Mental Health, Mannheim | 2015-04-01 |
| Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder (NCT02407340) | Johns Hopkins University | 2015-03-01 |
| Retinoic Acid Homeostasis in Neuropsychiatric Diseases (NCT02439099) | Charite University, Berlin, Germany | 2015-03-01 |
| ADHD: Gaps Between Patients With Alcohol-dependence and Impact on Relapse (NCT02364817) | University Hospital, Lille | 2015-01-01 |
| A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers (NCT02371889) | University of Pennsylvania | 2014-12-18 |
| The Role of Neural Systems for Emotion Regulation in Coping With Alcohol Craving (NCT02316574) | New York State Psychiatric Institute | 2014-12-01 |
| The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism (NCT02262026) | Yale University | 2014-11-01 |
| The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues (NCT02939352) | Medical University of South Carolina | 2014-09-01 |
| Mifepristone Treatment of Alcohol Use Disorder (NCT02179749) | The Scripps Research Institute | 2014-09-01 |
| Neural Substrates of Approach-Avoidance Conflict (NCT02119624) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2014-07-23 |
| Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study (NCT02181569) | National Institutes of Health Clinical Center (CC) | 2014-07-10 |
| Characterization Imaging Instruments in Alcoholics and Non-Alcoholics (NCT02108080) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2014-07-10 |
| Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse (NCT02242955) | University Hospital, Lille | 2014-07-01 |
| Behavioral and Functional Task Development, Implementation, and Testing (NCT02108054) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2014-05-28 |
| Medication Development in Alcoholism: Investigating PPAR Agonists (NCT02158273) | The Scripps Research Institute | 2014-05-01 |
| Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho (NCT02126696) | Swiss Tropical & Public Health Institute | 2014-05-01 |
| Ketamine Alcohol (in Treatment-Resistant Depression) (NCT02122562) | Mark Niciu | 2014-04-23 |
| Substance Dependence Satisfaction With Care and Quality Of Life (NCT02894476) | Central Hospital, Nancy, France | 2014-04-01 |
| Tailored Mobile Text Messaging to Reduce Problem Drinking (NCT01885312) | Northwell Health | 2014-02-01 |
| Efficacy and Safety of High Dose Baclofen for Alcohol Dependence (NCT01980706) | University of North Carolina, Chapel Hill | 2013-12-12 |
| Preventing Alcohol Withdrawal With Oral Baclofen (NCT01937364) | Essentia Health | 2013-11-01 |
| Tidal Model's Effect on Coping and Self-Esteem (NCT02604758) | Mahire Olcay Çam | 2013-10-01 |
| A Study of LY2940094 in Participants With Alcohol Dependency (NCT01798303) | BlackThorn Therapeutics, Inc. | 2013-07-01 |
| ARCH Research Protocol for Provider Alcohol Pharmacotherapy Training and Assessment (NCT02610517) | University of Alabama at Birmingham | 2013-06-01 |
| Project 4: Acute Effects of Alcohol on Learning and Habitization in Healthy Young Adults (NCT01858818) | Technische Universität Dresden | 2013-06-01 |
| Examination of Zinc, S-adenosylmethionine, and Combination Therapy Versus Placebo in Alcoholics (NCT01899521) | VA Office of Research and Development | 2013-05-01 |
| Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients (NCT01671501) | University of California, San Francisco | 2013-03-01 |
| Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease. (NCT01789008) | Rennes University Hospital | 2013-02-01 |
| ABT-436 for Alcohol Dependence (NCT01613014) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2013-02-01 |
| Integrated Alcohol Disorder and PTSD Treatment (NCT01601067) | VA Office of Research and Development | 2013-01-21 |
| Integrated Stepped Care for Unhealthy Alcohol Use in HIV (NCT01410123) | Yale University | 2013-01-01 |
| Pregabalin for Alcohol Dependence (NCT02205879) | St. Petersburg Bekhterev Research Psychoneurological Institute | 2013-01-01 |
| Dutasteride Treatment for the Reduction of Heavy Drinking in Men (NCT01758523) | UConn Health | 2013-01-01 |
| Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers (NCT01779024) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2012-12-13 |
| To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers (NCT01738867) | GlaxoSmithKline | 2012-12-12 |
| Baclofen for Treating Anxiety and Alcoholism (NCT01751386) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2012-12-03 |
| Deep Brain Stimulation for Refractory Alcoholism (NCT01798888) | National Institute of Neurological Disorders and Stroke (NINDS) | 2012-11-30 |
| Topiramate for Alcohol Use in Posttraumatic Stress Disorder (NCT01408641) | University of Maryland, Baltimore | 2012-09-01 |
| Consequences of At-risk Alcohol Consumption in ICU Patients (NCT03565016) | Nantes University Hospital | 2012-06-11 |
| Pharmacogenetic Treatments for Alcoholism (NCT01591291) | University of Virginia | 2012-06-01 |
| Baclofen for the Treatment of Alcohol Drinkers (NCT01604330) | Assistance Publique - Hôpitaux de Paris | 2012-05-29 |
| Component Analysis for Motivational Interviewing (NCT01642381) | Northwell Health | 2012-05-01 |
| A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease (NCT01504295) | Brown University | 2012-04-01 |
| Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists (NCT01548417) | The Scripps Research Institute | 2012-03-01 |